You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國人壽(02628.HK)擬合夥企業投資醫療健康和科技創新領域私募股權項目
格隆匯 12-16 19:30

格隆匯12月16日丨中國人壽(02628.HK)公吿,公司、財產險公司及無錫豐潤(各方均作為有限合夥人)擬與國壽成達(作為普通合夥人)及成達灃致(作為特殊有限合夥人)訂立合夥協議,藉以成立合夥企業。

合夥企業全體合夥人認繳出資總額為人民幣100億元,其中,公司認繳出資人民幣75億元。國壽股權將作為合夥企業的管理人。公司(作為有限合夥人)亦擬與國壽成達(作為普通合夥人)及國壽股權(作為管理人)訂立補充協議,以對合夥協議的條款作出更有利於本公司的修改和補充。各方擬於2021年12月31日前簽署合夥協議及補充協議。

合夥企業將主要直接或間接投資於醫療健康和科技創新領域的私募股權項目。其中,醫療健康領域圍繞四大核心賽道進行投資佈局,包括生命科學、醫療科技、醫療服務和流通、數字醫療,構建大健康產業生態,並專注於自主研發能力強、平台技術領先、國產替代優勢明顯的優質企業投資;科技創新領域主要關注三大投資方向,包括新經濟時代的新型基礎設施、核心技術平台以及產業升級應用,投資具備領先技術優勢、清晰商業模式、較高財務投資價值的優質科技標的。

合夥企業所投資領域以醫療健康及科技創新為主,是公司落實國家"健康中國"和"科技強國"戰略部署的體現。一方面,對醫療健康產業進行投資,有助於公司推進"大健康"、"大養老"戰略。

另一方面,通過對科技領域的投資,合夥企業有望整合被投企業的先進技術資源,推進新一代信息技術在公司的融合運用,提升公司科技創新能力和科技賦能水平。

交易有利於公司把握醫療健康產業數字化和智能化轉型升級的發展機遇,助力提升公司在戰略新興產業的資產配置和投資收益水平。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account